Positive correlation between blood cyclosporin A level and severity of gingival overgrowth in rats

Journal of Periodontology

Volumn 68, Issue 1, 1997, Pages 7-11

  Morisaki, Ichijiro ^a   Akiyama, Yoriko M ^a   Miyawaki, Yasuko N ^a   Mori, Yuko ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

cyclosporin adverse effects; gingival hyperplasia etiology

Indexed keywords

CYCLOSPORIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; GINGIVA HYPERPLASIA; HISTOLOGY; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT;

EID: 0031020951     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.1997.68.1.7     Document Type: Article

References (36)

1. Daley TD, Wysocki GP. Cyclosporine therapy. Its significance to the periodontist. J Periodontol 1984;55:708-712.
2. Hassell TM, Hefti AF. Drug-induced gingival overgrowth: Old problem, new problem. Crit Rev Oral Biol Med 1991;2:103-137.
3. Seymour RA, Jacobs DJ. Cyclosporin and the gingival tissues. J Clin Periodontol 1992;19:1-11.
4. Calne RY, Rolles K, White DJG, et al. Cyclosporin-A in clinical organ grafting. Transplant Proc 1981;13:349-358.
5. Rateitschak-Plüss EM, Hefti A, Lörtscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
6. Kahan BD. Cyclosporine. New Engl J Med 1989;321:1725-1738.
7. Butler RT, Kalkwarf KL, Kaldahl WB. Drug-induced gingival hyperplasia: Phenytoin, cyclosporine, and nifedipine. J Am Dent Assoc 1987;114:56-60.
8. Dongari A, McDonnell HT, Langlais RP. Drug-induced gingival overgrowth. Oral Surg Oral Med Oral Pathol 1993;76:543-548.
9. Pernu HE, Pernu LMH, Knuuttila MLE, Huttunen KRH. Gingival overgrowth among renal transplant recipients and uraemic patients. Nephrol Dial Transplant 1993;8:1254-1258.
10. Daley TD, Wysocki GP, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Pathol 1986;62:417-421.
11. Ross PJ, Nazif MM, Zullo T, Zitelli B, Guevara P. Effects of cyclosporin A on gingival status following liver transplantation. J Dent Child 1989;56:56-59.
12. Allman SD, McWhorter AG, Seale NS. Evaluation of cyclosporin-induced gingival overgrowth in the pediatric transplant patient. Pediatr Dent 1994;16:36-40.
13. McGaw T, Lam S, Coates J. Cyclosporin-induced gingival overgrowth: Correlation with dental plaque scores, gingivitis scores, and cyclosporin levels in serum and saliva. Oral Surg Oral Med Oral Pathol 1987;64:293-297.
14. Wondimu B, Dahllöf G, Berg U, Modéer T. Cyclosporin-A-induced gingival overgrowth in renal transplant children. Scand J Dent Res 1993;101:282-286.
15. Somacarrera ML, Hernández G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994;65:671-675.
16. Hefti AF, Eshenaur AE, Hassell TM, Stone C. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol 1994;65:744-749.
17. Seibel W, Yahia NA, McCleary LB, Lesko LJ, Hassell TM. Cyclosporine-induced gingival overgrowth in beagle dogs. J Oral Pathol Med 1989;18:240-245.
18. Morisaki I, Mihara J, Kato K. et al. Phenytoin-induced gingival overgrowth in rats infected with Streptococcus sobrinus 6715. Arch Oral Biol 1990;35:753-758.
19. Kitamura K, Morisaki I, Adachi C, et al. Gingival overgrowth induced by cyclosporin A in rats. Arch Oral Biol 1990;35:483-486.
20. Morisaki I, Kato K, Loyola-Rodriguez JP, Nagata T, Ishida H. Nifedipinc-induced gingival overgrowth in the presence or absence of gingival inflammation in rats. J Periodont Res 1993;28:396-403.
21. Ishida H, Kondoh T, Kataoka M, et al. Factors influencing nifedipine-induced gingival overgrowth in rats. J Periodontol 1995;66: 345-350.
22. Morisaki I, Kitamura K, Kato K, Marukawa Y, Mihara J. Age dependency of cyclosporin A-induced gingival overgrowth in rats. Pediatr Dent 1993;15:414-417.
23. Thomason JM, Seymour RA, Rice N. The prevalence and severity of cyclosporin and nifedipine-induced gingival overgrowth. J Clin Periodontol 1993;20:37-40.
24. Fu E, Nieh S, Chang HL, Wang SL. Dose-dependent gingival overgrowth induced by cyclosporin in rats. J Periodontol 1995;66:594-598.
25. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
26. King GN, Fullinfaw R, Higgins TJ, Walker RG, Francis DMA, Wiesenfeld D. Gingival hyperplasia in renal allograft recipients receiving cyclosporin-A and calcium antagonists. J Clin Periodontol 1993;20:286-293.
27. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol 1987;14:610-613.
28. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodont Res 1989;24:314-321.
29. Pernu HE, Pernu LMH, Huttunen KRH, Nieminen PA, Knuuttila MLE. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
30. Tyldesley WR, Rotter E. Gingival hyperplasia induced by cyclosporin-A. Br Dent J 1984;157:305-309.
31. Seibel W, Sundberg JP, Lesko LJ, Sauk JJ, McCleary LB, Hassell TM. Cutaneous papillomatous hyperplasia in cyclosporine-A treated beagles. J Invest Dermatol 1989;93:224-230.
32. Thomason JM, Seymour RA, Ellis JS, et al. Iatrogenic gingival overgrowth in cardiac transplantation. J Periodontol 1995;66:742-746.
33. Bökenkamp A, Bohnhorst B, Beier C, Albers N, Offner G, Brodehl J. Nifedipine aggravates cyclosporine A-induced gingival hyperplasia. Pediatr Nephrol 1994;8:181-185.
34. Pagliarini A, Stabellini G, Carinci F, Calura G, Tognon M, Evangelisti R. Heterogeneity of fibroblasts derived from human free and attached gingiva. Glycosaminoglycan synthesis and effects of phenytoin (PTH) treatment. J Oral Pathol Med 1995;24:72-77.
35. McKevitt KMB, Irwin CR. Phenotypic differences in growth, matrix synthesis and response to nifedipine between fibroblasts derived from clinically healthy and overgrown gingival tissue. J Oral Pathol Med 1995;24:66-71.
36. McCulloch CAG, Knowles GC. Deficiencies in collagen phagocytosis by human fibroblasts in vitro: A mechanism for fibrosis? J Cell Physiol 1993;155:461-471.